ELISA Kit for Complement Receptor 1, Erythrocyte (CR1)
SEB123HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Complement Receptor 1, Erythrocyte (CR1)
- Delivery Days Customer12
- Assay Detection Range0.156-10ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Complement Receptor 1, Erythrocyte (CR1) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 0.055ng/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Complement Receptor 1, Erythrocyte (CR1). Standards or samples are then added to the ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Boldt ABW, Oliveira-Toré CF, Kretzschmar GC, et al. Hepatitis B Virus Infection Among Leprosy Patients: A Case for Polymorphisms Compromising Activation of the Lectin Pathway and Complement Receptors. Front Immunol. 2020,11:574457. doi: 10.3389/fimmu.2020.574457Read this paper
- Goetzl EJ, Schwartz JB, Abner EL, et al. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. 2018,83(3):544-552. doi: 10.1002/ana.25172Read this paper
- Sandri TL, Lidani KCF, Andrade FA, et al. Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease. Sci Rep. 2018,8(1):526. doi: 10.1038/s41598-017-18937-zRead this paper
- Daborg J, Andreasson U, Pekna M, et al. Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease. J Neural Transm (Vienna). 2012,119(7):789-97. doi: 10.1007/s00702-012-0797-8Read this paper
- Kullo IJ, Ding K, Shameer K, et al. Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate. Am J Hum Genet. 2011,89(1):131-8. doi: 10.1016/j.ajhg.2011.05.019Read this paper
